"Drs. Malanga, Bowen and Agesen of New Jersey Regenerative Institute specialize in non-surgical treatments of sports, spine and musculoskeletal issues with the highest quality regenerative cellular procedures (called "stem cell" by some). Their focus is on pain relief caused by orthopedic problems (arthritis, tendon problems [rotator cuff tears, tennis elbow], carpal tunnel, meniscus tears, knee/shoulder pain) by evaluating the patient's lifestyle, environment and underlying factors. With platelet rich plasma (PRP), adipose/Lipogems, or bone marrow, our physicians continue to have excellent results on a variety of patients who wished to avoid surgical procedures like knee and hip replacements/arthroscopy and carpal tunnel release surgery."

During the past decade, New Jersey Regenerative Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Regenerative Institute" #1 collaborator was "New Jersey Regenerative Institute, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "New Jersey Regenerative Institute" are "Knee Osteoarthritis" (2 trials), "Bone Marrow Edema" (1 trials), "Knee Pain Chronic" (1 trials), "Lumbar Disc Herniation" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "New Jersey Regenerative Institute" in a lesser frequency.

Most popular intervention types in "New Jersey Regenerative Institute" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Focused extracorporeal shockwave therapy" (1 trials), "GID SVF-2 Device System" (1 trials), "PSC-01" (1 trials), "SI-6603" (1 trials) and "Sham injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Jersey Regenerative Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "New Jersey Regenerative Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in New Jersey Regenerative Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New Jersey Regenerative Institute, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".